Category stocks

Biogen Q2 Earnings Call Highlights

MarketBeat Week in Review – 05/18 - 05/22 Biogen (NASDAQ:BIIB) reported second-quarter 2026 total revenue of $2.7 billion, up 3% from a year earlier, as growth products and the recently completed acquisition of Apellis contributed to results. Core pharmaceutical revenue ro